Journal of Medical Oncology and Therapeutics

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +44-7360-538437

Maximum efficient treatment of haemangiomas in infants

2nd Euro-Global Congress on Melanoma and Skin Diseases
August 31-September 01, 2017 London, UK

Hana Zelenkova

Private Clinic of Dermatovenerology, DOST Svidník, Slovakia

Keynote : J Med Oncl Ther


Haemangiomas are benign vascular tumours composed of an increased number of unique endothelial cells that line blood vessels. We distinguish between single capillary haemangiomas and haemangiomatosis, defined as multiple haemangiomas that may occur anywhere on the skin or mucous membranes. Haemangioma may occur in any location supplied with blood vessels (skin, internal organs, and bones). Capillary haemangiomas appear on skin or mucous membranes supplied through capillaries with a very small internal diameter. Haemangiomas affecting internal organs (liver, kidneys, brain, spleen or the lungs) are usually detected accidentally. The size of haemangioma, especially on the skin, ranges from millimetres to several centimetres, forming a bright red or bluish-red lesion. Haemangiomas are the most common benign tumours in infants, appearing in 3% of new-borns, usually affecting the face – the nose, the lips, the eyelids or the genitalia (labia minor, clitoris, scrotum), and they should be considered urgent conditions requiring an adequate treatment. An extraordinarily elegant and safe treatment with excellent results, practically without undesired effects is the oral administration of the beta-blocker propranolol. After the initial examination, the administration requires the cooperation of a dermatologist, a paediatrician, and a cardiologist. We are going to present the cases of our patients before and after six months of therapy with propranolol with an excellent effect on various localities on the skin.


Hana Zelenková has been active in the field of Dermatovenerology since 1973. Since 2000 she has been directing her own Private Clinic of Dermatovenerology. Her professional orientation is towards: aesthetic dermatology, acne and facial dermatoses, medicinal mycology (nail diseases), wound management, psoriasis, employment of Ichthyol and carboxytherapy in dermatology. She is the coordinator of many international multicentre trials. She has delivered more than 555 lectures as expert in the Slovak Republic as well as abroad, 440 scientific publications. She is Co-author of the Dermatocosmetic formulae containing Ichthammol and glycyrrhiziic acid. She is also the author of the book “Carboxytherapy” (2015) translated into 4 languages. She is regularly invited to deliver lectures at international congresses. She is the Founder and President of the Slovak Society for Aesthetic and Cosmetic Dermatology (SSEDK), Organizer and President of the traditional international DERMAPARTY congress. Since 2006, she is elected as the Vice-President European Society of Aesthetic and Cosmetic Dermatology, since 2007 President of the European Society of Aesthetic and Cosmetic Dermatology.

Get the App

Vizag Tech Summit